ClinicalTrials.gg
Sign In
Status unknownNCT03267355Updated Aug 30, 2017

Indications and Outcomes of Endoscopic Ultrasound in Tanta

An interventional study of Endoscopic Ultrasound in Gastric Disease, Intestinal Disease and Pancreatic Diseases, sponsored by Tanta University. Status unknown at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2017-08-30.

Sponsored by Tanta University · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Aug 2017), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Jan 2016, registered Aug 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Sex
All
01

Study summary

The aim is to evaluate the initial experience for the indications and outcomes of EUS in Tanta university hospital.

Read the detailed description

Detection of main causes for referral to EUS in Tanta, Egypt.

02

Conditions studied

  • Gastric Disease
  • Intestinal Disease
  • Pancreatic Diseases
  • Esophageal Diseases
03

In context

Stomach Diseases

53 studies on the registry are indexed under Stomach Diseases; 6 are open to participants now.

This study's planned enrollment of 50 is below the median of 75 across 39 interventional studies indexed under Stomach Diseases.

Browse Stomach Diseases studies →

Lead sponsor

Tanta University is the lead sponsor of 1,010 studies on the registry; 321 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Browse Tanta University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All cases of gastrointestinal EUS

Exclusion criteria

Exclusion Criteria:

  • Missed data
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Gastrointestinal diseases

    Endoscopic Ultrasound

    Device: Endoscopic Ultrasound

Interventions

  • DeviceEndoscopic Ultrasound

    Indication of EUS

    Also known as: EUS

06

What researchers measure

Primary outcomes

  1. Number of different indications for Endoscopic Ultrasound in Tanta, Egypt

    Evaluation of the initial experience of the indications and outcomes of GIT EUS

    Time frame: 10 months

07

Study locations

1 of 1 sites recruiting
  • Tanta university hospital
    Cairo, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2016 (actual). Primary completion is estimated for Jan 2019, 36 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2017
First posted
Aug 30, 2017
StartActual
Jan 2016
Primary completionEst.
Jan 2019
CompletionEst.
Dec 2019
Last update
Aug 30, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 30, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03267355
Lead sponsor
Tanta University
Responsible party
Sponsor
First posted
Aug 30, 2017
Start date
Jan 2016
Primary completion
Jan 2019 (estimated)
Completion
Dec 2019 (estimated)
Last update
Aug 30, 2017

Study contacts

Sherief Abd-Elsalam, Ph D
Contact
Sheriefabdelsalam@yahoo.com
00201095159522
Asem Elfert, Professor
principal investigator · Tanta University Faculty of Medicine
Ferial El-kalla, Professor
principal investigator · Tanta university Faculty of Medicine
Samah Mosaad, consultant
study director · Tanta University Faculty of Medicine
Walaa Elkhalawany, Consultant
study director · Tanta University Faculty of Medicine
Reham Elkhouly, Consultant
study chair · Tanta University Faculty of Medicine
Eslam Saber, Specialist
study chair · Tanta University Faculty of medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Stomach Diseases →

Other studies from this sponsor

Tanta University →

Start the discussion